This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Determine if AMD3100, given with a G-CSF mobilizing regimen is generally safe and well tolerated. Determine if AMD3100, given with a G-CSF mobilizing regimen will increase the number of peripheral stem cells collected for transplantation.
Showing the most recent 10 out of 1825 publications